BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gage M, Putra M, Wachter L, Dishman K, Gard M, Gomez-estrada C, Thippeswamy T. Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress. Antioxidants 2022;11:61. [DOI: 10.3390/antiox11010061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gage M, Vinithakumari AA, Mooyottu S, Thippeswamy T. Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration. Front Microbiom 2022;1. [DOI: 10.3389/frmbi.2022.1006078] [Reference Citation Analysis]
2 Du F, Tang T, Li Q, Liu J, Zhang F. Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications. Mediators of Inflammation 2022;2022:1-10. [DOI: 10.1155/2022/9112127] [Reference Citation Analysis]
3 Rao NS, Meyer C, Vasanthi SS, Massey N, Samidurai M, Gage M, Putra M, Almanza AN, Wachter L, Thippeswamy T. DFP-Induced Status Epilepticus Severity in Mixed-Sex Cohorts of Adult Rats Housed in the Same Room: Behavioral and EEG Comparisons. Front Cell Dev Biol 2022;10:895092. [PMID: 35620057 DOI: 10.3389/fcell.2022.895092] [Reference Citation Analysis]
4 Gage M, Gard M, Thippeswamy T. Characterization of Cortical Glial Scars in the Diisopropylfluorophosphate (DFP) Rat Model of Epilepsy. Front Cell Dev Biol 2022;10:867949. [DOI: 10.3389/fcell.2022.867949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]